[
  {
    "source": "Nuclear factor kappa-light-chain-enhancer of activated B cells",
    "target": "Inflammatory bowel disease",
    "relationship": "modulates",
    "description": "PTM can activate or inhibit signaling pathways like NF-κB, affecting IBD pathogenesis."
  },
  {
    "source": "Extracellular signal-regulated kinase",
    "target": "Inflammatory bowel disease",
    "relationship": "modulates",
    "description": "Modifications can activate or inhibit signaling pathways such as ERK, influencing the development of IBD."
  },
  {
    "source": "Protein kinase B",
    "target": "Inflammatory bowel disease",
    "relationship": "modulates",
    "description": "Changes in protein modifications can affect AKT signaling pathways involved in IBD."
  },
  {
    "source": "Interleukin-1 beta",
    "target": "Inflammatory bowel disease",
    "relationship": "regulates",
    "description": "Cytokines like IL-1β are modulated through protein modifications, impacting IBD."
  },
  {
    "source": "Tumor necrosis factor alpha",
    "target": "Inflammatory bowel disease",
    "relationship": "regulates",
    "description": "TNF-α levels can be altered by protein modifications, affecting inflammatory responses in IBD."
  },
  {
    "source": "Interferon gamma",
    "target": "Inflammatory bowel disease",
    "relationship": "regulates",
    "description": "Modifications can influence IFN-γ release, which plays a role in the immune response in IBD."
  }
]